{
  "actions": [
    {
      "acted_at": "2003-06-24", 
      "committee": "Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2003-06-24", 
      "committee": "House Energy and Commerce", 
      "references": [], 
      "text": "Referred to House Energy and Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2003-06-24", 
      "committee": "House Ways and Means", 
      "references": [], 
      "text": "Referred to House Ways and Means", 
      "type": "referral"
    }, 
    {
      "acted_at": "2003-07-01", 
      "in_committee": "House Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2003-07-02", 
      "in_committee": "House Ways and Means", 
      "references": [], 
      "subcommittee": "Trade", 
      "text": "Referred to the Subcommittee on Trade.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr2577-108", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }, 
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM", 
      "subcommittee": "Subcommittee on Trade", 
      "subcommittee_id": "04"
    }
  ], 
  "congress": "108", 
  "cosponsors": [
    {
      "district": "1", 
      "name": "Bishop, Rob", 
      "sponsored_at": "2003-06-24", 
      "state": "UT", 
      "thomas_id": "01753", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "23", 
      "name": "Bonilla, Henry", 
      "sponsored_at": "2003-09-17", 
      "state": "TX", 
      "thomas_id": "00107", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "31", 
      "name": "Carter, John R.", 
      "sponsored_at": "2003-07-09", 
      "state": "TX", 
      "thomas_id": "01752", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2003-06-24", 
  "number": "2577", 
  "official_title": "To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "district": "26", 
    "name": "Burgess, Michael C.", 
    "state": "TX", 
    "thomas_id": "01751", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2003-06-24", 
  "subjects": [
    "Commerce", 
    "Congress", 
    "Congressional investigations", 
    "Congressional reporting requirements", 
    "Drug industry", 
    "Drugs", 
    "Economics and public finance", 
    "Foreign trade and international finance", 
    "Health", 
    "International affairs", 
    "Nontariff trade barriers", 
    "Prescription pricing", 
    "Price regulation", 
    "Trade negotiations"
  ], 
  "subjects_top_term": "Foreign trade and international finance", 
  "summary": {
    "as": "Introduced", 
    "date": "2003-06-24", 
    "text": "Requires the Comptroller General to conduct a study and report to Congress on: (1) the impact of price controls on pharmaceuticals by foreign governments, including the impact on market access for U.S. pharmaceuticals and on pharmaceutical prices for U.S. consumers; and (2) the extent to which negotiations conducted by the U.S. Trade Representative under the Bipartisan Trade Promotion Authority Act of 2002 facilitate the elimination of such price controls."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-14T19:01:33-04:00"
}